Literature DB >> 16631785

The first holocomplex structure of ribonucleotide reductase gives new insight into its mechanism of action.

Malin Uppsten1, Mathias Färnegårdh, Vladimir Domkin, Ulla Uhlin.   

Abstract

Ribonucleotide reductase is an indispensable enzyme for all cells, since it catalyses the biosynthesis of the precursors necessary for both building and repairing DNA. The ribonucleotide reductase class I enzymes, present in all mammals as well as in many prokaryotes and DNA viruses, are composed mostly of two homodimeric proteins, R1 and R2. The reaction involves long-range radical transfer between the two proteins. Here, we present the first crystal structure of a ribonucleotide reductase R1/R2 holocomplex. The biological relevance of this complex is based on the binding of the R2 C terminus in the hydrophobic cleft of R1, an interaction proven to be crucial for enzyme activity, and by the fact that all conserved amino acid residues in R2 are facing the R1 active sites. We suggest that the asymmetric R1/R2 complex observed in the 4A crystal structure of Salmonella typhimurium ribonucleotide reductase represents an intermediate stage in the reaction cycle, and at the moment of reaction the homodimers transiently form a tight symmetric complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16631785     DOI: 10.1016/j.jmb.2006.03.035

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  26 in total

1.  Structural interconversions modulate activity of Escherichia coli ribonucleotide reductase.

Authors:  Nozomi Ando; Edward J Brignole; Christina M Zimanyi; Michael A Funk; Kenichi Yokoyama; Francisco J Asturias; Joanne Stubbe; Catherine L Drennan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases.

Authors:  Jun Wang; Gregory J S Lohman; JoAnne Stubbe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

3.  Closing the circle on ribonucleotide reductases.

Authors:  Derek T Logan
Journal:  Nat Struct Mol Biol       Date:  2011-03       Impact factor: 15.369

4.  The dimanganese(II) site of Bacillus subtilis class Ib ribonucleotide reductase.

Authors:  Amie K Boal; Joseph A Cotruvo; Joanne Stubbe; Amy C Rosenzweig
Journal:  Biochemistry       Date:  2012-04-25       Impact factor: 3.162

5.  High-field pulsed electron-electron double resonance spectroscopy to determine the orientation of the tyrosyl radicals in ribonucleotide reductase.

Authors:  V P Denysenkov; T F Prisner; J Stubbe; M Bennati
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

6.  Structural basis for activation of class Ib ribonucleotide reductase.

Authors:  Amie K Boal; Joseph A Cotruvo; JoAnne Stubbe; Amy C Rosenzweig
Journal:  Science       Date:  2010-08-05       Impact factor: 47.728

7.  Studying protein complexes by the yeast two-hybrid system.

Authors:  Seesandra V Rajagopala; Patricia Sikorski; J Harry Caufield; Andrey Tovchigrechko; Peter Uetz
Journal:  Methods       Date:  2012-07-24       Impact factor: 3.608

8.  Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.

Authors:  Don B Gammon; Branawan Gowrishankar; Sophie Duraffour; Graciela Andrei; Chris Upton; David H Evans
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

9.  Radical-translocation intermediates and hurdling of pathway defects in "super-oxidized" (Mn(IV)/Fe(IV)) Chlamydia trachomatis ribonucleotide reductase.

Authors:  Laura M K Dassama; Wei Jiang; Paul T Varano; Maria-Eirini Pandelia; Denise A Conner; Jiajia Xie; J Martin Bollinger; Carsten Krebs
Journal:  J Am Chem Soc       Date:  2012-12-04       Impact factor: 15.419

10.  Mapping the subunit interface of ribonucleotide reductase (RNR) using photo cross-linking.

Authors:  A Quamrul Hassan; JoAnne Stubbe
Journal:  Bioorg Med Chem Lett       Date:  2008-08-19       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.